A recent study published in the journal Diabetes Care found that the combination of Technosphere insulin (TI) plus insulin ...

Insulin human is under clinical development by Aerami Therapeutics and currently in Phase II for Type 2 Diabetes.

The effects of nateglinide on prandial glucose and insulin, fructosamine, fasting plasma glucose (FPG), and HbA 1c levels were also assessed. A total of 288 nondiabetic subjects (FPG <7.0 mmol/l ...

Postprandial hypoglycemia is one of the main complications of bariatric surgery and can affect up to 30% of patients. Unlike ...

CONCLUSIONS Increased GLP-1–stimulated insulin secretion contributes significantly to hyperinsulinism in GB subjects. However, the exaggerated effect of GLP-1 on postprandial insulin secretion ...

REHOVOT, Israel, Dec. 17, 2024 /PRNewswire/ -- Amai Proteins, a scale-up designer of novel proteins that answer the needs of ...